Who is sponsoring NCT06220721?

NCT06220721 is sponsored by Medical College of Wisconsin.

What drugs are being tested in NCT06220721?

Interventions in NCT06220721: Nifedipine ER.

What condition does NCT06220721 study?

NCT06220721 studies Hypertension, Pregnancy-Induced.

Is NCT06220721 still recruiting?

NCT06220721 is currently recruiting now. Last updated 11 May 2025.

Last reviewed 2025-05-11 · How we verify

NCT06220721: REPAIR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Reducing the Risk of Chronic Hypertension and Improving Vascular Function Following Preeclampsia

Recruiting now NA Last updated 11 May 2025

What this trial tests

NA trial testing Nifedipine ER in Hypertension, Pregnancy-Induced in 618 participants. Currently enrolling.

Timeline

23 October 2024

Primary endpoint
31 March 2029

30 June 2029

Quick facts

Lead sponsor	Medical College of Wisconsin
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	618
Start date	23 October 2024
Primary completion	31 March 2029
Estimated completion	30 June 2029
Sites	2 locations across United States

Drugs / interventions tested

Nifedipine ER

Conditions studied

Hypertension, Pregnancy-Induced — all drugs for Hypertension, Pregnancy-Induced →

Sponsor

Medical College of Wisconsin

Who can join

18 and older, female only, with Hypertension, Pregnancy-Induced. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The long-term goal of our work is to evaluate the effect of intensive postpartum blood pressure control on maternal cardiovascular health, risk of chronic hypertension, and reversal of vascular dysfunction generated by hypertensive disorders of pregnancy, thus attenuating the lifelong trajectory of cardiovascular disease risk.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hypertension, Pregnancy-Induced

Currently open trials in the same condition.

NCT05655936 — Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial · NA · recruiting
NCT07361679 — LDA and LMWH vs LDA Alone in High-risk Patients for Preeclampsia Prevention · Phase 4 · recruiting
NCT04012151 — Arm and Finger Measurement for Blood Pressure Surveillance · active not recruiting

Other Medical College of Wisconsin trials

Trials by the same sponsor.

NCT07260552 — Rapid Engagement for Solutions to Population and Outcomes Through Networked Dialogue for Coronary Heart Disease · not yet recruiting
NCT06795360 — Weight Changes After Incretin-mimetics · NA · not yet recruiting
NCT07228208 — Role of Endothelial Dysfunction on Exercise Pressor Reflex in Type 2 Diabetes · NA · not yet recruiting
NCT07298460 — Stimulation-based Therapy to Improve Balance in DCM · Phase 1, PHASE2 · not yet recruiting
NCT07434544 — Cardiometabolic Effects of Non-Nutritive Sweeteners (NNS) in Type 1 Diabetes (T1D) · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06220721 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical College of Wisconsin
Last refreshed: 11 May 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06220721.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing